foxo4 dri peptide senolytic 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI Peptide - Nationwide Peptides
FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOX04 DRI
Pay in 4 interest-free payments of $6.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




